Srivastava, S.Lundqvist, A.Berg, M.Yokoyama, H.Smith, A.2022-12-082022-12-082008-02-01Srivastava, S., Lundqvist, A., Berg, M., Yokoyama, H., Smith, A., McCoy, J. P., & Childs, R. (2008). 111: Lenalidomide Directly Upregulates NK (Natural Killer) Cell Trail and Granzyme B Expression: Implications for Adoptive NK Cell Immunotherapy following Allogeneic Hematopoietic Stem Cell Transplantation (HCT). Biology of Blood and Marrow Transplantation, 14(2, Supplement), 43. https://doi.org/10.1016/j.bbmt.2007.12.1201083-8791https://hdl.handle.net/1805/30683enAttribution-NonCommercial-NoDerivatives 4.0 InternationalHematopoietic Stem Cell Transplantation (HCT)Adoptive NK Cell ImmunotherapyGranzyme B Expression111: Lenalidomide Directly Upregulates NK (Natural Killer) Cell Trail and Granzyme B Expression: Implications for Adoptive NK Cell Immunotherapy following Allogeneic Hematopoietic Stem Cell Transplantation (HCT)Article